Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

IMMUNOTHERAPY

Inflammation-targeted vascular nanomedicine

Nature Biomedical Engineering volume 2, pages 269–270 (2018)Cite this article

Subjects

Lipoprotein nanoparticles delivering an inflammation-targeting signalling inhibitor reduce vascular inflammation in atherosclerotic mice.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Reduction of atherosclerosis by a targeted nanoimmunotherapy.

References

  1. Smith, S. C. Jr et al. J. Am. Coll. Cardiol. 58, 2432–2446 (2011).

    Article  PubMed  Google Scholar 

  2. Cooke, J. P. Methodist Debakey Cardiovasc. J. 3, 154–155 (2015).

    Article  Google Scholar 

  3. Franck, G. et al. Circ. Res. 12, 31–42 (2017).

    Article  CAS  Google Scholar 

  4. Ridker, P. M. et al. N. Engl. J. Med. 377, 1119–1131 (2017).

    Article  PubMed  CAS  Google Scholar 

  5. Ridker, P. M. Circ. Res. 118, 145–156 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Skajaa, T. et al. Arterioscler. Thromb. Vasc. Biol. 30, 169–176 (2010).

    Article  PubMed  CAS  Google Scholar 

  7. Tang, J. et al. Circulation 124, A9601 (2011).

    Google Scholar 

  8. Lameijer, M. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-018-0221-2 (2018).

  9. Libby, P., Ridker, P. M. & Hansson, G. K. J. Am. Coll. Cardiol. 54, 2129–2138 (2009).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Seijkens, T. T. P. et al. J. Am. Coll. Cardiol. 71, 527–542 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Cole, J. E. et al. Proc. Natl Acad. Sci. USA 108, 2372–2377 (2011).

    Article  PubMed  Google Scholar 

  12. Sayed, N. et al. Circulation 131, 300–309 (2015).

    Article  PubMed  CAS  Google Scholar 

  13. Buxton, D. B. et al. Circulation 108, 2737–2742 (2003).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kostas Center for Cardiovascular Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA

    John P. Cooke & Mauro Ferrari

  2. Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, USA

    John P. Cooke

  3. Deparment of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA

    Mauro Ferrari

Authors
  1. John P. Cooke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mauro Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mauro Ferrari.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cooke, J.P., Ferrari, M. Inflammation-targeted vascular nanomedicine. Nat Biomed Eng 2, 269–270 (2018). https://doi.org/10.1038/s41551-018-0241-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-018-0241-y

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing